<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2016</study_start_year><condition>Neoplasm Metastasis</condition><condition>Liver Metastases</condition><condition>Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><disease>Neoplasm Metastasis</disease><disease>Liver Metastases</disease><disease>Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2270610</full_dataset_link><location>Norway</location><study_start_month>12</study_start_month><keyword>Liver metastasis</keyword><repository>ECRIN MDR</repository><study_status>Recruiting</study_status></additional><is_claimable>false</is_claimable><name>Liver Transplantation Compared to Chemotherapy in Patients With ColoRectal Cancer</name><description>The trial is a randomized control trial. Patients are randomized between Ltx and other treatment that may include further chemotherapy, TACE, SIRT or other available treatment options. The patients will be randomized 1:1 to Ltx and chemotherapy/other treatment options.</description><dates><creation>2016-12-15</creation></dates><accession>2270610</accession><cross_references><ClinicalTrials___gov>NCT03494946</ClinicalTrials___gov></cross_references></HashMap>